130 related articles for article (PubMed ID: 38701136)
41. The evaluation of oxidative stress parameters in breast and colon cancer.
Kundaktepe BP; Sozer V; Durmus S; Kocael PC; Kundaktepe FO; Papila C; Gelisgen R; Uzun H
Medicine (Baltimore); 2021 Mar; 100(11):e25104. PubMed ID: 33725987
[TBL] [Abstract][Full Text] [Related]
42. Expression of pleiotrophin in small cell lung cancer.
Wang HQ; Wang J
J Biol Regul Homeost Agents; 2015; 29(1):175-9. PubMed ID: 25864755
[TBL] [Abstract][Full Text] [Related]
43. Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses.
Park BJ; Cha MK; Kim IH
BMC Res Notes; 2014 Jan; 7():7. PubMed ID: 24393391
[TBL] [Abstract][Full Text] [Related]
44. Brain metastasis-related microRNAs in patients with advanced breast cancer.
Sato J; Shimomura A; Kawauchi J; Matsuzaki J; Yamamoto Y; Takizawa S; Sakamoto H; Ohno M; Narita Y; Ochiya T; Tamura K
PLoS One; 2019; 14(10):e0221538. PubMed ID: 31603918
[TBL] [Abstract][Full Text] [Related]
45. Pleiotrophin and N-syndecan promote perineural invasion and tumor progression in an orthotopic mouse model of pancreatic cancer.
Yao J; Zhang LL; Huang XM; Li WY; Gao SG
World J Gastroenterol; 2017 Jun; 23(21):3907-3914. PubMed ID: 28638231
[TBL] [Abstract][Full Text] [Related]
46. Elevated expression of pleiotrophin in lymphocytic leukemia CD19+ B cells.
Du CX; Wang L; Li Y; Xiao W; Guo QL; Chen F; Tan XT
APMIS; 2014 Oct; 122(10):905-13. PubMed ID: 24698102
[TBL] [Abstract][Full Text] [Related]
47. The clinical importance of serum galectin-3 levels in breast cancer patients with and without metastasis.
Topcu TO; Kavgaci H; Gunaldi M; Kocoglu H; Akyol M; Mentese A; Yaman SO; Orem A; Ozdemir F; Aydin F
J Cancer Res Ther; 2018 Sep; 14(Supplement):S583-S586. PubMed ID: 30249872
[TBL] [Abstract][Full Text] [Related]
48. AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection.
Garczyk S; von Stillfried S; Antonopoulos W; Hartmann A; Schrauder MG; Fasching PA; Anzeneder T; Tannapfel A; Ergönenc Y; Knüchel R; Rose M; Dahl E
PLoS One; 2015; 10(4):e0122106. PubMed ID: 25875093
[TBL] [Abstract][Full Text] [Related]
49. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
[TBL] [Abstract][Full Text] [Related]
50. Marked increase of the growth factors pleiotrophin and fibroblast growth factor-2 in serum of testicular cancer patients.
Aigner A; Brachmann P; Beyer J; Jäger R; Raulais D; Vigny M; Neubauer A; Heidenreich A; Weinknecht S; Czubayko F; Zugmaier G
Ann Oncol; 2003 Oct; 14(10):1525-9. PubMed ID: 14504053
[TBL] [Abstract][Full Text] [Related]
51. Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer.
Wang-Johanning F; Li M; Esteva FJ; Hess KR; Yin B; Rycaj K; Plummer JB; Garza JG; Ambs S; Johanning GL
Int J Cancer; 2014 Feb; 134(3):587-95. PubMed ID: 23873154
[TBL] [Abstract][Full Text] [Related]
52. Anaplastic lymphoma kinase is expressed in different subtypes of human breast cancer.
Perez-Pinera P; Chang Y; Astudillo A; Mortimer J; Deuel TF
Biochem Biophys Res Commun; 2007 Jun; 358(2):399-403. PubMed ID: 17490616
[TBL] [Abstract][Full Text] [Related]
53. Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer.
Sasaki H; Yu CY; Dai M; Tam C; Loda M; Auclair D; Chen LB; Elias A
Breast Cancer Res Treat; 2003 Feb; 77(3):245-52. PubMed ID: 12602924
[TBL] [Abstract][Full Text] [Related]
54. Pleiotrophin, a multifunctional tumor promoter through induction of tumor angiogenesis, remodeling of the tumor microenvironment, and activation of stromal fibroblasts.
Perez-Pinera P; Chang Y; Deuel TF
Cell Cycle; 2007 Dec; 6(23):2877-83. PubMed ID: 18156802
[TBL] [Abstract][Full Text] [Related]
55. Luteolin suppresses colorectal cancer cell metastasis via regulation of the miR‑384/pleiotrophin axis.
Yao Y; Rao C; Zheng G; Wang S
Oncol Rep; 2019 Jul; 42(1):131-141. PubMed ID: 31059061
[TBL] [Abstract][Full Text] [Related]
56. Midkine and pleiotrophin concentrations in needle biopsies of breast and lung masses.
Giamanco NM; Jee YH; Wellstein A; Shriver CD; Summers TA; Baron J
Cancer Biomark; 2017 Sep; 20(3):299-307. PubMed ID: 28946562
[TBL] [Abstract][Full Text] [Related]
57. A novel discriminant score based on tumor-associated trypsin inhibitor for accurate diagnosis of metastasis in patients with breast cancer.
El-mezayen HA; Metwally FM; Darwish H
Tumour Biol; 2014 Mar; 35(3):2759-67. PubMed ID: 24222329
[TBL] [Abstract][Full Text] [Related]
58. The utility of serum tumor markers CEA and CA 15-3 for breast cancer prognosis and their association with clinicopathological parameters.
Uygur MM; Gümüş M
Cancer Treat Res Commun; 2021; 28():100402. PubMed ID: 34082362
[TBL] [Abstract][Full Text] [Related]
59. Association of serum endoglin with metastasis in patients with colorectal, breast, and other solid tumors, and suppressive effect of chemotherapy on the serum endoglin.
Takahashi N; Kawanishi-Tabata R; Haba A; Tabata M; Haruta Y; Tsai H; Seon BK
Clin Cancer Res; 2001 Mar; 7(3):524-32. PubMed ID: 11297243
[TBL] [Abstract][Full Text] [Related]
60. Pleiotrophin, an embryonic differentiation and growth factor, is expressed in osteoarthritis.
Pufe T; Bartscher M; Petersen W; Tillmann B; Mentlein R
Osteoarthritis Cartilage; 2003 Apr; 11(4):260-4. PubMed ID: 12681952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
